AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Other Medicines (Established / Legacy Brands) by Year
Other Medicines (Established / Legacy Brands) — Established RoW YoY CER (%) (%)
AstraZeneca Other Medicines (Established / Legacy Brands): -24.0% in FY2025, up 12.0 pts from a year earlier.
Where the FY2025 figure comes from
“|| Other Medicines | 972 | (9) | (8) | 63 | (43) | 732 | - | 1 | 84 | (19) | (20) | 93 | (25) | (24)”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Therapy Area Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Medicines (Established / Legacy Brands) — Established RoW YoY CER (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -24.0% | +12.0 pts | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | -36.0% | +25.0 pts | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | -61.0% | -111.0 pts | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 50.0% | +35.0 pts | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 15.0% | +12.0 pts | Form 6-K FY2021Q4 Earnings Release ↗ |
| FY2020 | Dec 31, 2020 | 3.0% | – | Form 6-K FY2020Q4 Earnings Release ↗ |
Cite this data
StockData. (2026). AstraZeneca Other Medicines (Established / Legacy Brands) (%), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/ta-other-meds-erow-cer-yoy
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.